Index nr
|
Kemiskt namn
|
EG-nr
|
CAS-nr
|
Klassificering
|
Märkning
|
Särskilda koncentrationsgränser, M-faktorer och uppskattad akut toxicitet (ATE)
|
Anm.:
|
Faroklass och farokategorikod(er)
|
Faroangivelsekod(er)
|
Faropiktogram, signalordskod(er)
|
Faroangivelsekod(er)
|
Kompl. faroangivelsekod(er)
|
”005-007-00-2
|
borsyra [1]
borsyra [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
”005-008-00-8
|
dibortrioxid
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
”005-011-00-4
|
tetrabordinatriumheptaoxid, hydrat; [1]
dinatriumtetraborat, vattenfri; [2]
ortoborsyra, natriumsalt [3]
dinatriumtetraboratdekahydrat [4]
dinatriumtetraboratpentahydrat [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
”006-069-00-3
|
tiofanatmetyl (ISO);
dimetyl-(1,2-fenylendikarbamotioyl)biskarbamat;
dimetyl-4,4′-(o-fenylen)bis(3-tioallofanat)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
inhalation: ATE = 1,7 mg/l
(damm och dimma)
M = 10
M = 10”
|
|
”006-076-00-1
|
mankozeb (ISO); manganetylenbis(ditiokarbamat) (polymert) komplex med zinksalt
|
-
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (sköldkörtel, nervsystem)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (sköldkörtel, nervsystem)
H317
H410
|
|
M = 10
M = 10”
|
|
”015-113-00-0
|
tolklofosmetyl (ISO);
O-(2,6-diklor-p-tolyl)-O,O-dimetyltiofosfat
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1”
|
|
”028-007-00-4
|
trinickeldisulfid;
nickelsubsulfid; [1]
heazlewoodit [2]
|
234-829-6 [1]
- [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
inhalation:
ATE = 0,92 mg/l
(damm eller dimma)”
|
|
”029-002-00-X
|
dikopparoxid;
koppar(I)oxid
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
inhalation: ATE = 3,34 mg/l (damm eller dimma)
oral: ATE = 500 mg/kg bw
M = 100
M = 10”
|
|
”029-015-00-0
|
koppartiocyanat
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10”
|
|
”029-016-00-6
|
koppar(II)oxid
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10”
|
|
”029-017-00-1
|
dikopparkloridtrihydroxid
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
inhalation: ATE = 2,83 mg/l (damm eller dimma)
oral: ATE = 299 mg/kg bw
M = 10
M = 10”
|
|
”029-018-00-7
|
tetrakopparhexahydroxidsulfat; [1]
tetrakopparhexahydroxidsulfathydrat [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
oral: ATE = 500 mg/kg bw
M = 10
M = 10”
|
|
”029-019-01-X
|
kopparflingor (överdragna med alifatisk syra)
|
-
|
-
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
inhalation: ATE = 0,733 mg/l (damm eller dimma)
oral: ATE = 500 mg/kg bw
M = 10
M = 10”
|
|
”029-020-00-8
|
koppar(II)karbonat--koppar(II)hydroxid (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
inhalation: ATE = 1,2 mg/l (damm eller dimma)
oral: ATE = 500 mg/kg bw
M = 10
M = 10”
|
|
”029-021-00-3
|
koppardihydroxid;
koppar(II)hydroxid
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
inhalation: ATE = 0,47 mg/l (damm eller dimma)
oral: ATE = 500 mg/kg bw
M = 10
M = 10”
|
|
”029-022-00-9
|
bordeauxvätska;
reaktionsprodukter av kopparsulfat med kalciumdihydroxid
|
-
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
inhalation: ATE = 1,97 mg/l (damm eller dimma)
M = 10
M = 1”
|
|
”029-023-00-4
|
kopparsulfatpentahydrat
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oral: ATE = 481 mg/kg bw
M = 10
M = 1”
|
|
”601-029-00-7
|
dipenten;
limonen [1]
(S)-p-menta-1,8-dien; l-limonen [2]
trans-1-metyl-4-(1-metylvinyl)cyklohexen; [3]
(±)-1-metyl-4-(1-metylvinyl)cyklohexen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C”
|
”601-096-00-2
|
(R)-p-menta-1,8-dien;
d-limonen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1”
|
|
”603-024-00-5
|
1,4-dioxan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D”
|
”603-066-00-4
|
7-oxa-3-oxiranylbicyklo[4.1.0]heptan; 1,2-epoxi-4-epoxietylcyklohexan; 4-vinylcyklohexendiepoxid
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
inhalation: ATE = 0,5 mg/l (damm eller dimma)
oral: ATE = 1 847 mg/kg bw”
|
|
”603-098-00-9
|
2-fenoxietanol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
oral:
ATE = 1 394 mg/kg bw”
|
|
”606-004-00-4
|
4-metylpentan-2-on; isobutylmetylketon
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
inhalation: ATE = 11 mg/l (ångor)”
|
|
”607-421-00-4
|
cypermetrin (ISO);
α-cyano-3-fenoxibensyl-3-(2,2-diklorvinyl)-2,2-dimetylcyklopropankarboxylat; cypermetrin cis/trans +/- 40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (nervsystem)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (nervsystem)
H410
|
|
oral: ATE = 500 mg/kg bw
inhalation; ATE = 3,3 mg/l (damm eller dimma)
M = 100000
M = 100000”
|
|
”607-424-00-0
|
trifloxistrobin (ISO); metyl(E)-metoxiimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)etylidenaminooxi]-o-tolyl}acetat
|
-
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10”
|
|
”607-434-00-5
|
mekoprop-P (ISO) [1] och dess salter;
(R)-2-(4-klor-2-metylfenoxi)propionsyra [1] och dess salter
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oral: ATE = 431 mg/kg bw
M = 10
M = 10”
|
|
”608-058-00-4
|
esfenvalerat (ISO);
(S)-α-cyano-3-fenoxibensyl-(S)-2-(4-klorfenyl)-3-metylbutyrat
|
-
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (nervsystem)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (nervsystem)
H373
H317
H410
|
|
oral: ATE = 88,5 mg/kg bw
inhalation; ATE = 0,53 mg/l (damm eller dimma)
M = 10 000
M = 10 000 ”
|
|
”612-067-00-9
|
3-aminometyl-3,5,5-trimetylcyklohexylamin
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
oral: ATE = 1 030 mg/kg bw
Skin Sens. 1A; H317: C ≥ 0,001 %”
|
|
”612-252-00-4
|
imidakloprid (ISO);
(E)-1-(6-klor-3-pyridylmetyl)-N-nitroimidazolidin-2-ylidenamin;
(2E)-1-[(6-klorpyridin-3-yl)metyl]-N-nitroimidazolidin-2-imin
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
oral: ATE = 131 mg/kg bw
M = 100
M = 1 000 ”
|
|
”613-048-00-8
|
karbendazim (ISO); metylbensimidazol-2-ylkarbamat
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10”
|
|
”613-102-00-0
|
dimetomorf (ISO); (E,Z)-4-(3-(4-klorfenyl)-3-(3,4-dimetoxifenyl)akryloyl)morfolin
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411”
|
|
|
|
”613-111-00-X
|
1,2,4-triazol
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
oral: ATE = 1 320 mg/kg bw”
|
|
”613-166-00-X
|
flumioxazin (ISO);
N-(7-fluor-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-bensoxazin-6-yl)cyklohex-1-en-1,2-dikarboximid
|
-
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 ”
|
|
”613-208-00-7
|
imazamox (ISO);
(RS)-2-(4-isopropyl-4-metyl-5-oxo-2-imidazolin-2-yl)-5-metoximetylnikotinsyra
|
-
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|
”613-267-00-9
|
tiametoxam (ISO);
3-(2-klor-tiazol-5-ylmetyl)-5-metyl[1,3,5]oxadiazinan-4-yliden-N-nitroamin
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
oral: ATE = 780 mg/kg bw
M = 10
M = 10”
|
|
”613-282-00-0
|
tritikonazol (ISO);
(RS)-(E)-5-(4-klorbensyliden)-2,2-dimetyl-1-(1H-1,2,4-triazol-1-metyl)cyklopentanol
|
-
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1”
|
|
”616-032-00-9
|
diflufenikan (ISO);
N-(2,4-difluorfenyl)-2-[3-(trifluormetyl)fenoxi]-3-pyridinkarboxamid; 2′,4′-difluor-2-(α,α,α-trifluor-m-tolyloxi) nikotinanilid
|
-
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 ”
|
|
”616-106-00-0
|
fenmedifam (ISO); metyl 3-(3-metylkarbaniloyloxi)karbanilat
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10”
|
|
”616-113-00-9
|
desmedifam (ISO);
etyl-3-fenylkarbamoyloxifenylkarbamat
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|